Mark A. Winter
Impact in
- Oncology top 5%
- Drug Transport and Resistance Mechanisms
- Toxicology top 5%
- Bioactive Compounds and Antitumor Agents
Papers in
- Oncology 11
- Drug Transport and Resistance Mechanisms 11
-
- Cancer therapeutics and mechanisms 4
- DNA and Nucleic Acid Chemistry 2
- Co-authors
- Homer L. Pearce (5 shared papers)William T. Beck (3 shared papers)Anne H. Dantzig (7 shared papers)Robert L. Shepard (7 shared papers)Ahmad R. Safa (2 shared papers)Margaret C. Cirtain (2 shared papers)Nicholas J. Bach (2 shared papers)Sean Ekins (4 shared papers)
- Journals
- Molecular Pharmacology (5 papers)Journal of Medicinal Chemistry (2 papers)Proceedings of the National Academy of Sciences (2 papers)Bioorganic & Medicinal Chemistry Letters (2 papers)Biochemical Pharmacology (1 paper)
- Partner nations
- United States
In The Last Decade
Mark A. Winter
15 papers receiving 1.2k citations
Peers
Comparison fields: 5 of 82
- Oncology 703
- Toxicology 71
- Pharmacology 147
- Genetics 317
- Pediatrics, Perinatology and Child Health 179
Countries citing papers authored by Mark A. Winter
This map shows the geographic impact of Mark A. Winter's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark A. Winter with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark A. Winter more than expected).
Fields of papers citing papers by Mark A. Winter
This network shows the impact of papers produced by Mark A. Winter. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark A. Winter. The network helps show where Mark A. Winter may publish in the future.
Co-authors
The 25 scholars most cited alongside Mark A. Winter, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1997 | 220 | |
| 2 | 1989 | 213 | |
| 3 | 2002 | 161 | |
| 4 | 1997 | 158 | |
| 5 | 2002 | 145 | |
| 6 | 1997 | 75 | |
| 7 | 1990 | 71 | |
| 8 | 1990 | 62 | |
| 9 | 1998 | 49 | |
| 10 | 1995 | 33 | |
| 11 | 2002 | 31 | |
| 12 | 1999 | 24 | |
| 13 | 2002 | 17 | |
| 14 | 2006 | 7 | |
| 15 | Modulation of multiple drug resistance mdr in cem vlb 100 cells structure activity relationships in a series of 100 reserpine analogs | 1988 | 1 |
About Mark A. Winter
Mark A. Winter is a scholar working on Oncology, Molecular Biology, Infectious Diseases, Genetics and Organic Chemistry, having authored 15 papers that have together received 1.3k indexed citations. Recurring topics across this work include Drug Transport and Resistance Mechanisms (11 papers), Cancer therapeutics and mechanisms (4 papers), HIV/AIDS drug development and treatment (4 papers), Estrogen and related hormone effects (3 papers), DNA and Nucleic Acid Chemistry (2 papers), Adenosine and Purinergic Signaling (2 papers), Computational Drug Discovery Methods (2 papers) and Pharmacogenetics and Drug Metabolism (1 paper). The work is most often cited by research in Oncology (703 citations), Toxicology (71 citations), Pharmacology (147 citations), Genetics (317 citations) and Pediatrics, Perinatology and Child Health (179 citations). Mark A. Winter has collaborated with scholars based in United States. Frequent co-authors include Homer L. Pearce, William T. Beck, Anne H. Dantzig, Robert L. Shepard, Ahmad R. Safa, Margaret C. Cirtain, Nicholas J. Bach, Sean Ekins, Kazuto Yasuda and Steven Wrighton. Their work appears in journals such as Molecular Pharmacology, Journal of Medicinal Chemistry, Proceedings of the National Academy of Sciences, Bioorganic & Medicinal Chemistry Letters and Biochemical Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.